The previous page is sending you to https://biobuzz.io/inovio-doses-first-participant-in-phase-2-trial-for-its-dna-vaccine-against-middle-east-respiratory-syndrome-mers-a-coronavirus-disease/.

 If you do not want to visit that page, you can return to the previous page.